missing translation for 'onlineSavingsMsg'
Learn More

Cannabinoid R1/CB1/CNR1 Antibody (2A1), Novus Biologicals™

Human Monoclonal Antibody

343.00€ - 533.00€

Specifications

Antigen Cannabinoid R1/CB1/CNR1
Clone 2A1
Dilution ELISA
Applications ELISA
Classification Monoclonal
View More Specs

Products 2
Product Code Brand Quantity Price Quantity & Availability  
Product Code Brand Quantity Price Quantity & Availability  
30043032
View Documents
Novus Biologicals
NBP3-26648-50ul
50 μL
343.00€
50µL
View alternative products
Save Up to 
»
Please to purchase this item. Need a web account? Register with us today!
30043836
View Documents
Novus Biologicals
NBP3-26648-100ul
100 μL
533.00€
100µL
View alternative products
Save Up to 
»
Please to purchase this item. Need a web account? Register with us today!
Description

Description

Cannabinoid R1/CB1/CNR1 Monoclonal antibody specifically detects Cannabinoid R1/CB1/CNR1 in Human samples. It is validated for ELISA
Specifications

Specifications

Cannabinoid R1/CB1/CNR1
ELISA
Monoclonal
Purified
RUO
Human
CANN6CB1R, cannabinoid receptor 1 (brain), CB1A, CB1K5, CB-RCB1cannabinoid receptor 1, central cannabinoid receptor, CNR
Recombinant Human Cannabinoid R1/CB1/CNR1 protein [UniProt P21554]
Primary
Store at -20 to -70C. Avoid freeze-thaw cycles.
2A1
ELISA
Unconjugated
Human
Cancer, GPCR, Neuroscience, Neurotransmission, Vision
50% Glycerol, 0.01M PBS, PH 7.4
1268
IgG4
Affinity purified
Videos
SDS
Documents

Documents

Product Certifications
Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Thank You! Your feedback has been submitted. Fisher Scientific is always working to improve our content for you. We appreciate your feedback.